BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

607 related articles for article (PubMed ID: 25444473)

  • 1. Transarterial chemoembolization for primary liver malignancies and colorectal liver metastasis.
    Miura JT; Gamblin TC
    Surg Oncol Clin N Am; 2015 Jan; 24(1):149-66. PubMed ID: 25444473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transarterial approaches to primary and secondary hepatic malignancies.
    Habib A; Desai K; Hickey R; Thornburg B; Lewandowski R; Salem R
    Nat Rev Clin Oncol; 2015 Aug; 12(8):481-9. PubMed ID: 25985939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional therapies for metastatic colorectal carcinoma to the liver--an evidence-based review.
    Xing M; Kooby DA; El-Rayes BF; Kokabi N; Camacho JC; Kim HS
    J Surg Oncol; 2014 Aug; 110(2):182-96. PubMed ID: 24760444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoembolization of hepatic malignancy.
    Gonsalves CF; Brown DB
    Abdom Imaging; 2009; 34(5):557-65. PubMed ID: 18668189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transarterial Chemoembolization and (90)Y Radioembolization for Hepatocellular Carcinoma: Review of Current Applications Beyond Intermediate-Stage Disease.
    Fidelman N; Kerlan RK
    AJR Am J Roentgenol; 2015 Oct; 205(4):742-52. PubMed ID: 26397322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization, transarterial chemotherapy, and intra-arterial chemotherapy for hepatocellular carcinoma treatment.
    Tsochatzis EA; Germani G; Burroughs AK
    Semin Oncol; 2010 Apr; 37(2):89-93. PubMed ID: 20494700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term survival after transarterial chemoembolization for hepatocellular carcinoma.
    Iozzino M; Spaziani E; Picchio M; Saltarelli A; Di Filippo A; De Angelis F; Narilli F; Stagnitti F; Cianni R
    Clin Ter; 2011; 162(2):129-32. PubMed ID: 21533319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in transarterial embolotherapies in the treatment of hepatocellular carcinoma.
    Lee EW; Khan S
    Clin Mol Hepatol; 2017 Dec; 23(4):265-272. PubMed ID: 29113030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcatheter treatment of hepatic metastases.
    Pentecost MJ
    AJR Am J Roentgenol; 1993 Jun; 160(6):1171-5. PubMed ID: 8388617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial hepatic chemoembolization with 70-150 µm drug-eluting beads: assessment of clinical safety and liver toxicity profile.
    Odisio BC; Ashton A; Yan Y; Wei W; Kaseb A; Wallace MJ; Vauthey JN; Gupta S; Tam AL
    J Vasc Interv Radiol; 2015 Jul; 26(7):965-71. PubMed ID: 25979305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transarterial therapies for primary liver tumors.
    Talenfeld AD; Sista AK; Madoff DC
    Surg Oncol Clin N Am; 2014 Apr; 23(2):323-51. PubMed ID: 24560113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemoembolization of hepatic malignancies.
    Soulen MC
    Oncology (Williston Park); 1994 Apr; 8(4):77-84; discussion 84, 89-90 passim. PubMed ID: 8003400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of focal liver ablation in the treatment of unresectable primary and secondary malignant liver tumors.
    Gannon CJ; Curley SA
    Semin Radiat Oncol; 2005 Oct; 15(4):265-72. PubMed ID: 16183480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemoembolization and ethanol ablation of primary hepatic carcinoma and metastatic tumors].
    Rudzki S; Jamroz A
    Pol Merkur Lekarski; 2004 Jan; 16(91):78-81. PubMed ID: 15074029
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional Therapies for Colorectal Liver Metastases: Systematic Review and Clinical Practice Guideline.
    Karanicolas P; Beecroft JR; Cosby R; David E; Kalyvas M; Kennedy E; Sapisochin G; Wong R; Zbuk K;
    Clin Colorectal Cancer; 2021 Mar; 20(1):20-28. PubMed ID: 33257278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transarterial chemoembolization and yittrium-90 for liver cancer and other lesions.
    Minocha J; Salem R; Lewandowski RJ
    Clin Liver Dis; 2014 Nov; 18(4):877-90. PubMed ID: 25438288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transarterial chemoembolization with additional cisplatin infusion for hepatocellular carcinoma invading the hepatic vein.
    Kim HC; Lee JH; Chung JW; Kang B; Yoon JH; Kim YJ; Lee HS; Jae HJ; Park JH
    J Vasc Interv Radiol; 2013 Feb; 24(2):274-83. PubMed ID: 23369561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transarterial chemoembolization (TACE) for unresectable hepatocellular carcinoma in cirrhotics: functional hepatic reserve and survival.
    Grieco A; Marcoccia S; Miele L; Marmiroli L; Caminiti G; Ragazzoni E; Cotroneo AR; Cefaro GA; Rapaccini GL; Gasbarrini G
    Hepatogastroenterology; 2003; 50(49):207-12. PubMed ID: 12630024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prediction model for liver abscess developing after transarterial chemoembolization in patients with hepatocellular carcinoma.
    Shin JU; Kim KM; Shin SW; Min SY; Park SU; Sinn DH; Gwak GY; Choi MS; Lee JH; Paik SW; Yoo BC; Koh KC
    Dig Liver Dis; 2014 Sep; 46(9):813-7. PubMed ID: 24881853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-operative transarterial chemoembolization for resectable hepatocellular carcinoma adversely affects post-operative patient outcome.
    Kim IS; Lim YS; Lee HC; Suh DJ; Lee YJ; Lee SG
    Aliment Pharmacol Ther; 2008 Feb; 27(4):338-45. PubMed ID: 18047564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.